Restless Leg Syndrome (RLS) is characterized by a recurring irresistible urge to move the legs, usually to relieve discomfort. The etiology of RLS is complex, but clinical evidence favors involvement of dopaminergic neural activity especially given the partial therapeutic efficacy of dopamine agonists. Furthermore, iron (Fe) deficiency has been reported in the brains of some familial and non-familial RLS cases. Notably, alterations in serum and brain Fe status have been strongly associated with reciprocal changes in body and brain manganese (Mn) status. Genome wide association studies have implicated common variants in at least two genes (MEIS1 and BTBD9) to be associated with more than a 50% increase risk for RLS. This competing renewal application seeks to establish a Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER), to test the hypothesis that RLS is associated with alterations in systemic and neuronal Mn status that are influenced by RLS genetic risk loci. We will evaluate gene-environment interactions between Mn exposure and neuronal Mn status with genetic risk factors for RLS expanding the scope of the parent R01, which explores mechanisms of Mn neurotoxicity of the dopaminergic system and identifies modifiers of cellular Mn status in the context of Parkinson's disease (PD) and PD genetic risk factors.
In Specific Aim 1, we will test the hypothesis that RLS patients will exhibit elevated brain and/or serum Mn levels influenced by the patients Fe status and inheritance of genetic risk factors (e.g. common variants of MEIS1 and BTBD9).
In Specific Aim 2, we will test the hypothesis that lymphocytes isolated from RLS patients will exhibit Fe-deficiency related phenotypes and alteration in cellular Mn levels modulated by their RLS genetic risk status.
In Specific Aim 3, we will identify the functional relationship between meis1 and btbd9 knockdown in worms with Mn and Fe loads, and the ability of small molecules to rescue C. elegans from the RLS phenotype.
In Specific Aim 4, we will test the hypothesis that dopaminergic neuronal progenitors differentiated from induced pluripotent stem cells (iPSCs) derived from RLS patients will exhibit differences in Mn transport biology influenced by common variants in MEIS1 and BTBD9. The seamless organizational structure and the researchers'enthusiasm ensures that this innovative ViCTER will provide insight into both basic biology and the mechanistic events leading to RLS, develop techniques that will provide opportunities to understand and reduce RLS, and assesses genomic information to make better-supported individual decisions about diagnosis and treatment that are tailored to the biology of the specific patient.

Public Health Relevance

Restless Legs Syndrome (RLS) is one of the most common neurological disorders and as many as 10% of the United Sates population may have RLS, with moderate to severe RLS affecting 2-3% of adults. The proposed studies will (1) provide novel information on the role of manganese (Mn) in the etiology of RLS, (2) delineate gene- environment interactions within and across species that hasten the development of RLS, and (3) identify potential therapeutic modalities for this syndrome. Overall, the principal investigators seek to test the hypothesis that RLS is associated with alterations in systemic and neuronal Mn status that are influenced by RLS genetic risk loci.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
3R01ES010563-13S1
Application #
8625594
Study Section
Special Emphasis Panel (ZES1-JAB-D (VT))
Program Officer
Hollander, Jonathan
Project Start
2000-07-01
Project End
2016-10-31
Budget Start
2014-03-04
Budget End
2014-10-31
Support Year
13
Fiscal Year
2014
Total Cost
$426,274
Indirect Cost
$75,375
Name
Albert Einstein College of Medicine
Department
Pharmacology
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Karki, Pratap; Johnson Jr, James; Son, Deok-Soo et al. (2017) Transcriptional Regulation of Human Transforming Growth Factor-? in Astrocytes. Mol Neurobiol 54:964-976
Bryan, Miles R; Bowman, Aaron B (2017) Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders. Adv Neurobiol 18:113-142
Ruden, Douglas M; Gurdziel, Katherine; Aschner, Michael (2017) Frontiers in Toxicogenomics in the Twenty-First Century-the Grand Challenge: To Understand How the Genome and Epigenome Interact with the Toxic Environment at the Single-Cell, Whole-Organism, and Multi-Generational Level. Front Genet 8:173
Neely, M Diana; Davison, Carrie Ann; Aschner, Michael et al. (2017) From the Cover: Manganese and Rotenone-Induced Oxidative Stress Signatures Differ in iPSC-Derived Human Dopamine Neurons. Toxicol Sci 159:366-379
Ruszkiewicz, Joanna A; Pinkas, Adi; Ferrer, Beatriz et al. (2017) Neurotoxic effect of active ingredients in sunscreen products, a contemporary review. Toxicol Rep 4:245-259
Liu, Xinqin; Su, Peng; Meng, Shanshan et al. (2017) Role of matrix metalloproteinase-2/9 (MMP2/9) in lead-induced changes in an in vitro blood-brain barrier model. Int J Biol Sci 13:1351-1360
Li, Xiaobo; Yang, Hongbao; Wu, Shenshen et al. (2017) Suppression of PTPN6 exacerbates aluminum oxide nanoparticle-induced COPD-like lesions in mice through activation of STAT pathway. Part Fibre Toxicol 14:53
Isaacs, David; Claassen, Daniel; Bowman, Aaron B et al. (2017) Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 Mutations. Brain Sci 7:
Pfalzer, Anna C; Bowman, Aaron B (2017) Relationships Between Essential Manganese Biology and Manganese Toxicity in Neurological Disease. Curr Environ Health Rep 4:223-228
Hollmann, Emma K; Bailey, Amanda K; Potharazu, Archit V et al. (2017) Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells. Fluids Barriers CNS 14:9

Showing the most recent 10 out of 183 publications